Skip to content

Assessing how effective giving oral Pregabalin before surgery is in reducing pain after knee replacement surgery.

Efficacy of Preemptive oral Pregabalin in reduction of acute post operative pain in patients undergoing Total Knee Arthroplasty in a tertiary care hospital in Chengalpattu district A double blind randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060814
Enrollment
128
Registered
2023-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Oral Pregabalin: Pregabalin 150mg given orally as a single stat dose 6 hours before surgery Control Intervention1: Vitamin Tablets (Placebo): one vitamin tablet given orally as a single

Sponsors

Annie Sharon Priyanka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fit under ASA I and II

Exclusion criteria

Exclusion criteria: 1) Patients with uncontrolled systemic diseases such as systemic hypertension and diabetes mellitus 2) Patients with previous abdominal surgeries 3) Patients with psychiatric illness 4) Patients with chronic pain conditions

Design outcomes

Primary

MeasureTime frame
To determine whether Pregabalin before surgery could provide adequate pain relief in combination with patient-controlled analgesia by assessing the VAS scoresTimepoint: VAS scores assessed during recovery and postoperative period.

Secondary

MeasureTime frame
1) To observe the timing of first dose of analgesic in post-operative period (breakthrough analgesia) 2) To observe the occurrence of post-operative nausea and vomiting in patientsTimepoint: Post operative period

Countries

India

Contacts

Public ContactAnnie Sharon Priyanka

Shri Sathya Sai Medical College and Research Institute

dr.vijay@live.in9444877188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026